MMS currently expects underlying net profit after tax (UNPATA) for the first half of FY21 to be $42.7 million.
It may be $7.5m-$8.0m higher than broker's. Roughly 18% higher
- Forums
- ASX - By Stock
- mms time to buy
MMS currently expects underlying net profit after tax (UNPATA)...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MMS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.90 |
Change
0.040(0.24%) |
Mkt cap ! $1.177B |
Open | High | Low | Value | Volume |
$17.05 | $17.11 | $16.87 | $2.163M | 127.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1856 | $16.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.91 | 547 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 253 | 16.900 |
7 | 779 | 16.890 |
7 | 1021 | 16.880 |
5 | 551 | 16.870 |
4 | 705 | 16.860 |
Price($) | Vol. | No. |
---|---|---|
16.910 | 450 | 6 |
16.920 | 182 | 8 |
16.930 | 1056 | 11 |
16.940 | 347 | 4 |
16.950 | 667 | 6 |
Last trade - 14.26pm 15/07/2024 (20 minute delay) ? |
Featured News
MMS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online